This research found that patients who received albumin showed better clinical outcomes in cirrhotic patients with recurrent ascites by extending their periods without paracentesis and decreasing complications like PICD, renal dysfunction, and readmission to hospitals. The findings justify integrating albumin into the post-paracentesis care protocols by showing that it had clear therapeutic value over saline, especially in an under-resourced setting. This evidence concerns the gene ALB and Ascites.